Applications of palladium-catalyzed C–N cross-coupling reactions

P Ruiz-Castillo, SL Buchwald - Chemical reviews, 2016 - ACS Publications
Pd-catalyzed cross-coupling reactions that form C–N bonds have become useful methods to
synthesize anilines and aniline derivatives, an important class of compounds throughout …

Comprehensive review in current developments of benzimidazole‐based medicinal chemistry

RS Keri, A Hiremathad, S Budagumpi… - Chemical biology & …, 2015 - Wiley Online Library
The properties of benzimidazole and its derivatives have been studied over more than one
hundred years. Benzimidazole derivatives are useful intermediates/subunits for the …

Therapeutic evolution of benzimidazole derivatives in the last quinquennial period

W Akhtar, MF Khan, G Verma… - European journal of …, 2017 - Elsevier
Benzimidazole, a fused heterocycle bearing benzene and imidazole has gained
considerable attention in the field of contemporary medicinal chemistry. The moiety is of …

[HTML][HTML] γ-Secretase inhibitors and modulators

TE Golde, EH Koo, KM Felsenstein, BA Osborne… - … et Biophysica Acta (BBA …, 2013 - Elsevier
Abstract γ-Secretase is a fascinating, multi-subunit, intramembrane cleaving protease that is
now being considered as a therapeutic target for a number of diseases. Potent, orally …

Conformational restriction: an effective tactic in'follow-on'-based drug discovery

Z Fang, Y Song, P Zhan, Q Zhang… - Future medicinal …, 2014 - Taylor & Francis
The conformational restriction (rigidification) of a flexible ligand has often been a commonly
used strategy in drug design, as it can minimize the entropic loss associated with the ligand …

Development and mechanism of γ-secretase modulators for Alzheimer's disease

CJ Crump, DS Johnson, YM Li - Biochemistry, 2013 - ACS Publications
γ-Secretase is an aspartyl intramembranal protease composed of presenilin, Nicastrin,
Aph1, and Pen2 with 19 transmembrane domains. γ-Secretase cleaves the amyloid …

Gamma secretase modulators: new Alzheimer's drugs on the horizon?

MG Bursavich, BA Harrison… - Journal of medicinal …, 2016 - ACS Publications
The rapidly aging population desperately requires new therapies for Alzheimer's disease.
Despite years of pharmaceutical research, limited clinical success has been realized, with …

Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases

D Vanda, P Zajdel, M Soural - European Journal of Medicinal Chemistry, 2019 - Elsevier
This article provides an overview of compounds based on imidazo [1, 2-a] pyridine, imidazo
[1, 5-a] pyridine, imidazo [4, 5-b] pyridine and imidazo [4, 5-c] pyridine scaffolds, which act as …

Applications of palladium-catalyzed C–N cross-coupling reactions in pharmaceutical compounds

R Emadi, AB Nekoo, F Molaverdi, Z Khorsandi… - RSC …, 2023 - pubs.rsc.org
C–N cross-coupling bond formation reactions have become valuable approaches to
synthesizing anilines and their derivatives, known as important chemical compounds …

Regioselective Direct C-3 Arylation of Imidazo[1,2-a]pyridines with Aryl Tosylates and Mesylates Promoted by Palladium–Phosphine Complexes

PY Choy, KC Luk, Y Wu, CM So, L Wang… - The Journal of Organic …, 2015 - ACS Publications
Direct C-3 arylation of imidazo [1, 2-a] pyridines with aryl tosylates and mesylates has been
accomplished by employing palladium (II) acetate associated with SPhos (2 …